Tuesday, October 26, 2021 10:00:58 AM
CoroWare Subsidiary, CarbonMeta Research Ltd, Appoints Board of Director Members
Press Release | 10/26/2021
Founding members bring decades of management and technology leadership
OXFORD, ENGLAND and WOODINVILLE, WA / ACCESSWIRE / October 26, 2021 / CoroWare (OTC PINK:COWI) today announced that CarbonMeta Research Ltd, a wholly owned subsidiary of CoroWare that is based in Oxford, England, appointed Tiancun Xiao and Mohammed Khalil to the subsidiary's Board of Directors.
Dr. Xiao is a Senior Research Fellow at University of Oxford, has contributed to the development of novel catalysts and corresponding process for microwave assisted catalysis, which can selectively break C-H or C-C bond in hydrocarbons, including natural gas, liquid hydrocarbon, wax and polymers such as polyethylene, polypropylene, polystyrene and tyres. Dr Xiao has rich experiences in commercializing patent and transferring to industrial operation. He co-founded Oxford Catalyst Ltd in 2004, now rebranded as Velocys. He is also a co-founder of OxCCU Tech Ltd, a spinout company from Oxford University focusing on thermally catalysis in converting CO2 into aviation fuel or valuable chemicals.
Mr. Khalil is the co-founder of EcoMENA, an award-winning environmental platform that fosters sustainability, waste management and renewable energy in the Middle East and North Africa region. Mr. Khalil is also the Director and Co-Founder of Fusor Tech, an additive manufacturing company based in the England that is focused on producing advanced metal parts and additive manufacturing technologies for the space, oil & gas, marine and medical industries.
"I could not be more excited to welcome and announce the appointments of Mr. Khalil and Dr. Xiao to the Board of Directors of CarbonMeta Research," said Lloyd Spencer, Chairman and CEO of CoroWare., "They bring decades of leadership in key areas such as strategy implementation, technology development, and operational management, all of which will be vital to the success of CarbonMeta Research and CoroWare."
Mr. Khalil will serve as Managing Director, Dr. Xiao will serve as Chief Technology Officer, and Mr. Spencer will serve as Chairman of the Board of Directors of CarbonMeta Research Ltd.
About CarbonMeta Research Ltd.
CarbonMeta Research Ltd. is a wholly owned subsidiary of CoroWare that is based in the United Kingdom, and whose focus will be on the development of technologies and solutions for processing organic wastes and generating economically sustainable hydrogen and high-value carbon products.
For more information about the company, please visit www.carbonmetaresearch.co.uk.
About CoroWare Inc.
CoroWare Inc. (OTC PINK:COWI), headquartered in Woodinville, Washington, is in the early stage of transitioning into a resource reclamation company that will process organic wastes and generate economically sustainable hydrogen and high-value carbon products.
For more information about the company, please visit www.CoroWare.com.
Just copied and pasted from web, this is and always has been a LONG play so day flippers who think they will become millionaires over night STAY AWAY.
Lloyd is really trying, so far followed through with everything he has said he would do
Just my opinion
GLTA
Recent COWI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/01/2023 09:20:45 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:47:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 12:30:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/22/2023 07:13:47 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 12:35:32 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 07/17/2023 02:06:52 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 06/28/2023 06:46:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM